GLP-1 weight-loss drugs are getting a major upgrade
Digest more
The U.S. Food and Drug Administration has approved Omeros' drug for a dangerous transplant complication in adults and children two years and older, marking the first treatment to be greenlit for the condition,
The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneously administered therapy for patients with epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC).
A shaky economy, wider adoption of weight-loss drugs, and changing tastes seem to conspire against some food makers.
IL, and U.S. Rep. Rosa DeLauro, D-CT, have reintroduced the Federal Food Administration Act. The act is designed to streamline the U.S. food safety system by consolidating the Food and Drug Administra
Expanded use of GLP-1 drugs may lead to more side effects, already the subject of thousands of lawsuits now moving through the courts. Thousands of
After Reviewing Historical Use and Modern Safety Evidence, Officially Confirms Kava is a Food Under Federal Law